Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Randomized Controlled Trial of Fixed Low-Vs Moderate-Dose Hydroxyurea for Primary Stroke Prevention in Sub-Saharan Africa: Final Results of the Spring Trial

Shehu Umar Abdullahi, MBBS, Binta W. Jibir, MBBS, Halima Bello-Manga, MBBS, MPH, FMCPath, Safiya Gambo, MBBS, FWACP, Hauwa Inuwa, MBBS, Aliyu Gaya Tijjani, MBBS, Aisha Amal Galadanci, MBBS, Awwal Musa Borodo, MBBS, FMCPath, Najibah Aliyu Galadanci, MBBS,MPH, Nura Idris, MBBS, FWACS, Abulkadir M Tabari, MBBS, FMCR, FICS, Lawal Haliru, MBBS, Khadija Bulama, BNSc, Gloria Bahago, RN, Mohammed A. Sani, B. Pharm, MSc, Aisha Suleiman, MBBS, Murtala Umar, B. Pharm, Charity Dooshima, Agba, B. Pharm, Aisha Kazaure, B. Pharm, Bilya Sani Musa, BSc, MPPA, MHE, Fahad M Usman, BSc, Abdulrasheed Sani, MIM, Awwal Gambo, PGDM, MD, Jamila S. Ibrahim, MBBS, MScPH, PMCPead, Mustapha Hikima, MBBS, FWACP, Aisha B. Musa, MBBS, Abdu H. Dambatta, MBBS, FWACP, Jamil Aliyu Galadanci, BSc, MSc, Brittany Covert Greene, MPH, CCRP, Djamila Labib Ghafuri, MPH, Mark Rodeghier, PhD, James Slaughter, PhD, Fenella Jane Kirkham, MD, Kathleen Neville, MD MS, FAAP, FCCP, Adetola A. Kassim, MDMS, Muktar Aliyu, MBBS, DrPH, MPH, Lori C. Jordan, MD PhD, Edwin Trevathan, MD MPH, Michael R. DeBaun, MD MPH

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-141436

Published: 2020

Journal Articles

Low- Versus Moderate-Dose Hydroxyurea for Secondary Stroke Prevention in Children with Sickle Cell Disease in Sub-Saharan Africa: Final Results of a Randomized Controlled Trial, Sprint Trial

Shehu Umar Abdullahi, MBBS, Surayya M. Sunusi, Mohammed Sani Abba, Saifuddeen Sani, Aisha Galadanci, MBBS, Hauwa Inuwa, MBBS, Binta W. Jibir, MBBS, Brittany Covert Greene, MPH, CCRP, Adetola A. Kassim, MDMS, Lori C. Jordan, MD PhD, Muktar Aliyu, MBBS, DrPH, MPH, Mark Rodeghier, PhD, Awwal Musa Borodo, MBBS, FMCPath, Bilya Sani Musa, BSc, MPPA, MHE, Habu Abdu, Michael R. DeBaun, MD MPH

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-142896

Published: 2020

Journal Articles

Silent Cerebral Infarcts and Cerebral Aneurysms Are Prevalent in Adults with Sickle Cell Disease

Adetola A. Kassim, MD, Sumit Pruthi, MD, Matthew Day, MD, Michael R. DeBaun, MD MPH, Lori C. Jordan, MD

Blood (2014) 124 (21): 2712.

https://doi.org/10.1182/blood.V124.21.2712.2712

Published: 2014

Journal Articles

Acceptability and Safety of Hydroxyurea for Primary Prevention of Stroke in Children with Sickle Cell Disease in Nigeria

Michael R. DeBaun, MD MPH, Najibah Aliyu Galadanci, MBBS, Shehu U. Abdullahi, MD FWACPaed, Musa A. Tabari, MBBS, FMCR, FICS, Shehi Abubakar, MBBS, Raymond Belonwu, MBBS, FWACPaed, Auwal Salihu, MBBS, FMCPsych, Kathleen A Neville, MD MS, Fenella J. Kirkham, MD, Baba PD Inusa, MD FRCPCH, DCP, Yu Shyr, PhD, Sharon Phillips, MSPH, Adetola A. Kassim, MD, Lori C. Jordan, MD, Muktar H. Aliyu, MD DrPH, MPH, Brittany V. Covert, MPH

Blood (2014) 124 (21): 4021.

https://doi.org/10.1182/blood.V124.21.4021.4021

Published: 2014

Journal Articles

Acute Silent Cerebral Ischemia Occurs More Frequently Than Silent Cerebral Infarction In Children with Sickle Cell Anemia

Charles T. Quinn, MD, MS, Robert C. McKinstry, MD, PhD, Michael M. Dowling, MD, PhD, MSCS, William S. Ball, MD, Michael A. Kraut, MD, PhD, James F. Casella, MD, Nomazulu Dlamini, MBBS, MRCPCH, MSc, Rebecca N. Ichord, MD, Lori C. Jordan, MD, Fenella J. Kirkham, MD, FRCPCH, Michael J. Noetzel, MD, E. Steve Roach, MD, Deborah Hirtz, MD, Michael R. DeBaun, MD, MPH

Blood (2010) 116 (21): 268.

https://doi.org/10.1182/blood.V116.21.268.268

Published: 2010

Journal Articles

Predictors of Acute Intracranial Pathology Identified by Computerized Tomography in Children with Sickle Cell Disease.

John J. Strouse, MD, Rachel Rau, MD, Lori C. Jordan, MD, James F. Casella, MD

Blood (2006) 108 (11): 3798.

https://doi.org/10.1182/blood.V108.11.3798.3798

Published: 2006

NARROW

Randomized Controlled Trial of Fixed Low-Vs Moderate-Dose Hydroxyurea for Primary Stroke Prevention in Sub-Saharan Africa: Final Results of the Spring Trial

Low- Versus Moderate-Dose Hydroxyurea for Secondary Stroke Prevention in Children with Sickle Cell Disease in Sub-Saharan Africa: Final Results of a Randomized Controlled Trial, Sprint Trial

Silent Cerebral Infarcts and Cerebral Aneurysms Are Prevalent in Adults with Sickle Cell Disease

Acceptability and Safety of Hydroxyurea for Primary Prevention of Stroke in Children with Sickle Cell Disease in Nigeria

Acute Silent Cerebral Ischemia Occurs More Frequently Than Silent Cerebral Infarction In Children with Sickle Cell Anemia

Predictors of Acute Intracranial Pathology Identified by Computerized Tomography in Children with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Randomized Controlled Trial of Fixed Low-Vs Moderate-Dose Hydroxyurea for Primary Stroke Prevention in Sub-Saharan Africa: Final Results of the Spring Trial

Low- Versus Moderate-Dose Hydroxyurea for Secondary Stroke Prevention in Children with Sickle Cell Disease in Sub-Saharan Africa: Final Results of a Randomized Controlled Trial, Sprint Trial

Silent Cerebral Infarcts and Cerebral Aneurysms Are Prevalent in Adults with Sickle Cell Disease

Acceptability and Safety of Hydroxyurea for Primary Prevention of Stroke in Children with Sickle Cell Disease in Nigeria

Acute Silent Cerebral Ischemia Occurs More Frequently Than Silent Cerebral Infarction In Children with Sickle Cell Anemia

Predictors of Acute Intracranial Pathology Identified by Computerized Tomography in Children with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only